CareLit · DOI-Nachweis · Pneumologie
In vitro dose comparison of Respimat® Soft Inhaler™ with dry powder inhalers for COPD maintenance therapy
DOI 10.1055/s-0034-1367831
Bibliografische Angaben
Nachweis in CareLit
Autor:innenAM Ciciliani, D Bickmann, H Wachtel
ZeitschriftPneumologie
Ausgabe02/2014
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Background: A head-to-head comparison of contemporary inhalers in real patients is difficult because of the variability inevitably introduced by the patients. Therefore in-vitro data on the dose passing the mouth-throat region was acquired using the realistic Alberta throat model. Three inhalers (Respimat®, Breezhaler®, and Genuair®) were compared. Providing flow profiles, the effect of the air flow rate can be well…
Zitieren
Zitierempfehlung
AM Ciciliani, D Bickmann, H Wachtel (2014) In vitro dose comparison of Respimat® Soft Inhaler™ with dry powder inhalers for COPD maintenance therapy. Pneumologie (02). https://doi.org/10.1055/s-0034-1367831
Mit CareLit weiterarbeiten